DCDong Ho Choi

Dong Ho Choi

*This is an algorithmically generated author record based on publicly available information.

Dong Ho Choi has a total of 9 co-authors. Here are the top co-authors by number of shared publications:

  • Hongmin Chu

    Department of Internal Medicine Wonkwang University Gwangju Medical Center Gwangju Korea

    1 shared publication
  • Hyung Won Kang

    Department of Korean Neuropsychiatry Medicine, College of Korean Medicine, Wonkwang University, Iksan 54538, Republic of Korea

    1 shared publication
  • Jongwon Jang

    Department of Acupuncture and Moxibustion Medicine Wonkwang University Gwangju Medical Center Gwangju Korea

    1 shared publication
  • Joonyoung Shin

    Institute for Global Rare Disease Network, Professional Graduate School of Korean Medicine, Wonkwang University, Iksan 54538, Republic of Korea

    1 shared publication
  • Ju-Hun Park

    Haeundae Jaseng Hospital of Korean Medicine, Busan 48102, Korea

    1 shared publication
  • Kyungtae Park

    Department of Rehabilitation Medicine of Korean Medicine Wonkwang University Gwangju Medical Center Gwangju Korea

    1 shared publication

Latest Publications

  • Open Access

    Repeated-Dose Toxicity Testing of Scolopendrid Pharmacopuncture in Sprague-Dawley Rats

    by Jongwon Jang, Wookcheol Seo, Hongmin Chu, Kyungtae Park, SunKyung Kim, Ju-Hun Park, Joon Young Shin, Dong Ho Choi, Hyung Won Kang, Sungchul Kim

    Background: The aim of this pilot study was to assess the safety and dosing of scolopendrid pharmacopuncture (SPP).Methods: A total of 40 healthy Sprague-Dawley rats (males and 20 females 20) were selected following a 7-day inspection and acclimation period. SPP was administered via intramuscular injection, over a 2-week period using 3 doses including a high-dose [0.84 mg of scolopendrid per kg of body weight (BW)], a meddose (0.42 mg/kg BW), and a low-dose (0.21 mg/kg BW). The control group was injected with sterile water into the muscles. Unusual changes caused by administration of the test substance were observed. Weight, feed intake, organ weight, and hematological examinations were compared among the groups. Using the SPSS statistical program, Levene’s test was performed to evaluate the homogeneity of variances, and a one-way ANOVA test was subsequently performed to assess the significance between each test group.Results: During the experiment no animals died. Weight change, food consumption, organ weight, hematological test, and blood biochemical tests showed no significant differences in the treatment groups compared to controls.Conclusion: No toxicological changes related to the administration of test substances were observed. Therefore, the LD50 (lethal-dose that kills 50%) of scolopendrid pharmacoupuncture in rats was greater than 0.84 mg/kg.